TORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules...Read More
TORONTO, ON / ACCESSWIRE / May 30, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dy...Read More
(TheNewswire) Toronto, Ontario, May 27, 2024 – TheNewswire – Tantalex Lithium Resources Corp. (CSE: TTX – FSE: DW8 – OTCQB: TTLXF) (“Tantalex” or the “Corporation”), is pleased to announce a second tranche closing of a non-brokered pri...Read More
(TheNewswire) Toronto, Ontario, May 27, 2024 – TheNewswire – Tantalex Lithium Resources Corp. (CSE: TTX – FSE: DW8 – OTCQB: TTLXF) (“Tantalex” or the “Corporation”), is pleased to announce a second tranche closing of a non-brokered pri...Read More
(TheNewswire) Toronto, Ontario – TheNewswire - May 6, 2024 – Tantalex Lithium Resources Corp. (CSE:TTX) – (FSE:DW8) – (OTCQB:TTLXF) (“Tantalex” or the “Corporation”), is pleased to announce a first tranche closing of a non-br...Read More
(TheNewswire) Toronto, Ontario – TheNewswire - May 6, 2024 – Tantalex Lithium Resources Corp. (CSE:TTX) – (FSE:DW8) – (OTCQB:TTLXF) (“Tantalex” or the “Corporation”), is pleased to announce a first tranche closing of a non-br...Read More
TORONTO, ON / ACCESSWIRE / May 2, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Com...Read More
(TheNewswire) Toronto, Ontario, April 29th, 2024 – TheNewswire – Tantalex Lithium Resources Corp. (CSE: TTX – FSE: DW8 – OTCQB: TTLXF) (“Tantalex” or the “Corporation”) is pleased to announce a non-brokered private placemen...Read More
(TheNewswire) Toronto, Ontario, April 29th, 2024 – TheNewswire – Tantalex Lithium Resources Corp. (CSE: TTX – FSE: DW8 – OTCQB: TTLXF) (“Tantalex” or the “Corporation”) is pleased to announce a non-brokered private placemen...Read More
TORONTO, ON / ACCESSWIRE / April 24, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF)(FRA:TTX), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo...Read More
(TheNewswire) Toronto, Ontario, April 23rd, 2024 – TheNewswire – Tantalex Lithium Resources Corp. (CSE: TTX – FSE: DW8 – OTCQB: TTLXF) (“Tantalex” or the “Corporation”) is pleased to announce that its majority owned Joi...Read More
TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic C...Read More
TORONTO, ON / ACCESSWIRE / March 27, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic...Read More
TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds ("PD...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / March 22, 2024 – Tantalex Lithium Resources Corp. (CSE: TTX – FSE: DW8 – OTCQB: TTLXF) (“Tantalex” or the “Corporation”) announces that further to its news release dated March 7, 2024, it has settled...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / March 22, 2024 – Tantalex Lithium Resources Corp. (CSE: TTX – FSE: DW8 – OTCQB: TTLXF) (“Tantalex” or the “Corporation”) announces that further to its news release dated March 7, 2024, it has settled...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / March 7, 2024 – Tantalex Lithium Resources Corp. (CSE:TTX) (FSE:DW8) (OTC:TTLXF) (“Tantalex” or the “Corporation”) announces that further to its news release dated February 21, 2024, it has settled various outstan...Read More
(TheNewswire) Toronto, Ontario / TheNewswire / March 7, 2024 – Tantalex Lithium Resources Corp. (CSE:TTX) (FSE:DW8) (OTC:TTLXF) (“Tantalex” or the “Corporation”) announces that further to its news release dated February 21, 2024, it has settled various outstan...Read More
(TheNewswire) Toronto, Ontario – TheNewswire - February 21, 2024 – Tantalex Lithium Resources Corp. (CSE: TTX – FSE: DW8 – OTCQB: TTLXF) (“Tantalex” or the “Corporation”) intends to settle outstanding debts with various cre...Read More
TORONTO, ON / ACCESSWIRE / February 12, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynam...Read More